Quantum mechanical/X-ray crystallography diagnostic for proteins
An analytic method for improving the efficiency in identifying protein molecular effect information using low resolution x-ray crystallography, by selecting and imaging a protein sample with low resolution x-ray crystallography and assaying the data thus generated as to local ligand strain energy value, followed by calculating a real-space difference density Z for each element and compiling ZDD data therefrom, followed by determining the true protomer/tautomer state of the protein sample by calculating Score i according to the following equation so that the highest Score i signifies the molecular effect information: Score i ={(( ZDD i −μ ZDD )/σ ZDD )+((SE i −σ SE )/σ SE )}.
1. An analytic method more efficiently to identify conformational, protonation, or solvent effect information from a real world molecule of interest by using low resolution x-ray crystallography, comprising the steps of: a) selecting an aliquot of a real world molecule sample as a molecule to be diagnosed; b) imaging said molecule by low resolution x-ray crystallography and collecting a quantity of crystallography data generated thereby; c) assaying x-ray density within said crystallography data and creating from said crystallography data thus assayed a population set containing a plurality of set elements consisting of one or more of conformational, protonation or solvent effect information of said real world molecule; d) determining a local ligand strain energy value SE for each of said elements; e) determining ZDD for each of said elements by calculating a real-space difference density Z for each element and compiling ZDD data therefrom; and f) selecting a single element from among said elements that represents the true conformational, protonation or solvent effect information for at least one moiety of said molecule by calculating Score i according to the following equation,
Score i ={(( ZDD i −μ ZDD )/σ ZDD )+((SE i −σ SE )/σ SE )}
wherein the highest Score i obtained for said population corresponds to the best conformational, protonation or solvent effect form “i” that fits both SE and ZDD criteria, so that Score i when output to a user identifies the element from said population that most closely corresponds with said real world molecule thus diagnosed with increased time efficiency using said low resolution x-ray crystallography compared to the same method using atomic resolution x-ray crystallography.
2. An analytic method to identify conformational, protonation, or solvent effect information from a real world molecule of interest by using low resolution x-ray crystallography having a maximum resolution of 1.1 angstrom, comprising the steps of: a) selecting an aliquot of a real world molecule sample as a molecule to be diagnosed; b) imaging said molecule by low resolution x-ray crystallography and collecting a quantity of crystallography data generated thereby; c) assaying x-ray density within said crystallography data and creating from said crystallography data thus assayed a population set containing a plurality of set elements consisting of one or more of conformational, protonation or solvent effect information of said real world molecule; d) determining a local ligand strain energy value SE for each of said elements; e) determining ZDD for each of said elements by calculating a real-space difference density Z for each element and compiling ZDD data therefrom; and f) selecting a single element from among said elements that represents the true conformational, protonation or solvent effect information for at least one moiety of said molecule by calculating Score i according to the following equation,
Score i ={(( ZDD i −μ ZDD )/σ ZDD )+((SE i −σ SE )/σ SE )}
wherein the highest Score i obtained for said population corresponds to the best conformational, protonation or solvent effect form “i” that fits both SE and ZDD criteria, so that Score i when output to a user identifies the element from said population that most closely corresponds with said real world molecule thus diagnosed with increased time efficiency using said low resolution x-ray crystallography compared to the same method using atomic resolution x-ray crystallography.
3. The method of claim 1 , wherein said molecule further is a molecular ligand.
4. The method of claim 3 , wherein said ligand is a drug candidate ligand.